サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：がん免疫療法の世界市場調査レポート：産業分析、規模、調査シェア、成長、動向、2023～2030年予測
市場調査レポート
商品コード
1306946

がん免疫療法の世界市場調査レポート：産業分析、規模、調査シェア、成長、動向、2023～2030年予測

Global Cancer Immunotherapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日
ページ情報
英文 186 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
がん免疫療法の世界市場調査レポート：産業分析、規模、調査シェア、成長、動向、2023～2030年予測
出版日: 2023年06月01日
発行: Value Market Research
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

がん免疫療法市場の世界需要は、2022年の1,170億9,000万米ドルから2030年には2,369億3,000万米ドル近くの市場規模に達すると推定され、調査期間2023～2030年のCAGRは9.21%です。

がん免疫療法（免疫腫瘍学）とは、がんと闘うために身体の免疫システムの驚くべき能力を利用する治療アプローチを指します。免疫系は、がんを含む様々な疾患に対する身体固有の防御機構として機能します。免疫系は様々な細胞、組織、臓器から構成されており、それらが連携してがん細胞を含む異常な細胞を識別し、破壊します。

市場力学：

がん免疫療法市場は、いくつかの重要な要因により大きな成長を遂げています。まず、世界的にがんの罹患率が上昇しており、効果的な治療オプションに対する需要が高まっています。免疫療法は様々な種類のがんを標的とする可能性があり、有望な解決策として浮上しています。第二に、生存率や長期予後の改善など、免疫療法の良好な臨床結果がその採用を後押ししています。第三に、新規ターゲットの発見や併用療法の開発など、免疫療法技術の進歩が治療効果を高めています。政府のイニシアチブ、資金援助、規制プロセスの合理化も、市場の成長を促進する上で重要な役割を果たしています。さらに、製薬企業と研究機関の協力や提携が、この分野の技術革新を加速させています。投資と市場競争の激化により、多様な免疫治療薬が開発されています。個々の患者に合わせて治療を行う個別化医療のアプローチは、市場をさらに押し上げています。さらに、免疫治療薬の適応拡大と承認により、潜在的な患者層が拡大しています。全体として、これらの要因は進行中の調査や技術の進歩と相まって、がん免疫療法市場の継続的な成長を促進すると予想されます。

本レポートでは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、がん免疫療法の世界市場における各セグメントを包括的に評価することもできます。がん免疫療法産業の成長と動向は、本調査に総合的なアプローチを提供します。

地域分析：

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるがん免疫療法市場の現在および将来の需要を明らかにする地域展望をカバーします。さらに、全主要地域における各用途セグメントの需要、推定・予測にも焦点を当てています。

この調査はまた、市場の主要企業の包括的なプロファイルと世界の競合情勢の詳細な見解をカバーしています。The major players in the cancer immunotherapy market include Pfizer Inc, AstraZeneca, Merck &Co., Inc;F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Novartis AG, Lilly, Johnson &Johnson Services, Inc;Immunocore, Ltd.このセクションは、主要なM&A、将来的な能力、パートナーシップ、財務概要、提携、新製品開発、新製品発売などの様々な戦略的発展を含む競合情勢の全体像で構成されています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたものを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 がん免疫療法- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 がん免疫療法の世界市場分析：製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • モノクローナル抗体
  • 免疫調節薬
  • がん溶解性ウイルス療法およびがんワクチン

第6章 がん免疫療法の世界市場分析：用途別

  • 概要：用途別
  • 実績データと予測データ
  • 分析：用途別
  • 肺がん
  • 乳がん
  • 大腸がん
  • 黒色腫
  • 前立腺がん
  • 頭頸部がん
  • 卵巣がん
  • 膵臓がん
  • その他

第7章 がん免疫療法の世界市場分析：流通チャネル別

  • 流通チャネル別概要
  • 実績データと予測データ
  • 流通チャネル別分析
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第8章 がん免疫療法の世界市場分析：エンドユース別

  • エンドユース別概要
  • 実績データと予測データ
  • エンドユース別分析
  • 病院および診療所
  • がん研究センター
  • その他

第9章 がん免疫療法の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績および予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績および予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績および予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績および予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績および予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第10章 がん免疫療法企業の競合情勢

  • がん免疫療法市場の競合
  • 提携/共同研究/契約
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Pfizer Inc
  • AstraZeneca
  • Merck & Co. Inc
  • F. Hoffmann-La Roche Ltd
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Lilly
  • Johnson & Johnson Services Inc
  • Immunocore Ltd

注-企業プロファイルにおいて、財務の詳細や最近の動向は、非公開会社の場合、入手可能であるか、またはカバーされていない可能性があります。

図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Monoclonal Antibodies Market Sales by Geography (USD MN)
  • Immunomodulators Market Sales by Geography (USD MN)
  • Oncolytic Viral Therapies & Cancer Vaccines Market Sales by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Lung Cancer Market Sales by Geography (USD MN)
  • Breast Cancer Market Sales by Geography (USD MN)
  • Colorectal Cancer Market Sales by Geography (USD MN)
  • Melanoma Market Sales by Geography (USD MN)
  • Prostate Cancer Market Sales by Geography (USD MN)
  • Head & Neck Cancer Market Sales by Geography (USD MN)
  • Ovarian Cancer Market Sales by Geography (USD MN)
  • Pancreatic Cancer Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacy Market Sales by Geography (USD MN)
  • Retail Pharmacy Market Sales by Geography (USD MN)
  • Online Pharmacy Market Sales by Geography (USD MN)
  • Analysis by End Use (USD MN)
  • Hospitals & Clinics Market Sales by Geography (USD MN)
  • Cancer Research Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Cancer Immunotherapy Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cancer Immunotherapy
  • Market Research Process
  • Market Research Methodology
  • Global Cancer Immunotherapy Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by End Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Monoclonal Antibodies Market Sales by Geography (USD MN)
  • Immunomodulators Market Sales by Geography (USD MN)
  • Oncolytic Viral Therapies & Cancer Vaccines Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Lung Cancer Market Sales by Geography (USD MN)
  • Breast Cancer Market Sales by Geography (USD MN)
  • Colorectal Cancer Market Sales by Geography (USD MN)
  • Melanoma Market Sales by Geography (USD MN)
  • Prostate Cancer Market Sales by Geography (USD MN)
  • Head & Neck Cancer Market Sales by Geography (USD MN)
  • Ovarian Cancer Market Sales by Geography (USD MN)
  • Pancreatic Cancer Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacy Market Sales by Geography (USD MN)
  • Retail Pharmacy Market Sales by Geography (USD MN)
  • Online Pharmacy Market Sales by Geography (USD MN)
  • Global Market Analysis by End Use (USD MN)
  • Hospitals & Clinics Market Sales by Geography (USD MN)
  • Cancer Research Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the and are not limited to the TOC.

目次
Product Code: VMR112111378

The global demand for Cancer Immunotherapy Market is presumed to reach the market size of nearly USD 236.93 BN by 2030 from USD 117.09 BN in 2022 with a CAGR of 9.21% under the study period 2023 - 2030.

Cancer immunotherapy, or immuno-oncology, refers to a treatment approach that utilizes the remarkable capabilities of the body's immune system to combat cancer. The immune system serves as the body's inherent defence mechanism against various diseases, including cancer. It consists of various cells, tissues, and organs that work together to identify and destroy abnormal cells, including cancer cells.

MARKET DYNAMICS:

The cancer immunotherapy market is witnessing significant growth due to several key factors. First, there is a rising incidence of cancer worldwide, driving the demand for effective treatment options. Immunotherapy, with its potential to target various types of cancers, has emerged as a promising solution. Second, the favourable clinical outcomes of immunotherapy, including improved survival rates and long-term outcomes, have boosted its adoption. Third, advancements in immunotherapy techniques, such as the discovery of novel targets and the development of combination therapies, have enhanced treatment efficacy. Government initiatives, funding support, and streamlined regulatory processes have also played a crucial role in fueling market growth. Furthermore, collaborations and partnerships between pharmaceutical companies and research institutions have accelerated innovation in the field. Increased investment and market competition have resulted in the development of diverse immunotherapeutic agents. The personalized medicine approach, where treatments are tailored to individual patients, has further propelled the market. Additionally, expanded indications and approvals of immunotherapeutic agents have widened the potential patient population. Overall, these factors, coupled with ongoing research and technological advancements, are expected to drive continued growth in the cancer immunotherapy market.

The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cancer immunotherapy. The growth and trends of cancer immunotherapy industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cancer immunotherapy market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Monoclonal Antibodies
  • Immunomodulators
  • Oncolytic Viral Therapies & Cancer Vaccines

By Application

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Melanoma
  • Prostate Cancer
  • Head & Neck Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By End Use

  • Hospitals & Clinics
  • Cancer Research Centers
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cancer Immunotherapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cancer immunotherapy market include Pfizer Inc, AstraZeneca, Merck & Co., Inc; F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Novartis AG, Lilly, Johnson & Johnson Services, Inc; Immunocore, Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CANCER IMMUNOTHERAPY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By End Use
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CANCER IMMUNOTHERAPY MARKET ANALYSIS BY PRODUCT

  • 5.1 Overview by Product
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product
  • 5.4 Monoclonal Antibodies Historic and Forecast Sales by Regions
  • 5.5 Immunomodulators Historic and Forecast Sales by Regions
  • 5.6 Oncolytic Viral Therapies & Cancer Vaccines Historic and Forecast Sales by Regions

6 . GLOBAL CANCER IMMUNOTHERAPY MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Lung Cancer Historic and Forecast Sales by Regions
  • 6.5 Breast Cancer Historic and Forecast Sales by Regions
  • 6.6 Colorectal Cancer Historic and Forecast Sales by Regions
  • 6.7 Melanoma Historic and Forecast Sales by Regions
  • 6.8 Prostate Cancer Historic and Forecast Sales by Regions
  • 6.9 Head & Neck Cancer Historic and Forecast Sales by Regions
  • 6.10. Ovarian Cancer Historic and Forecast Sales by Regions
  • 6.11 Pancreatic Cancer Historic and Forecast Sales by Regions
  • 6.12 Others Historic and Forecast Sales by Regions

7 . GLOBAL CANCER IMMUNOTHERAPY MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1 Overview by Distribution Channel
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Distribution Channel
  • 7.4 Hospital Pharmacy Historic and Forecast Sales by Regions
  • 7.5 Retail Pharmacy Historic and Forecast Sales by Regions
  • 7.6 Online Pharmacy Historic and Forecast Sales by Regions

8 . GLOBAL CANCER IMMUNOTHERAPY MARKET ANALYSIS BY END USE

  • 8.1 Overview by End Use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End Use
  • 8.4 Hospitals & Clinics Historic and Forecast Sales by Regions
  • 8.5 Cancer Research Centers Historic and Forecast Sales by Regions
  • 8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL CANCER IMMUNOTHERAPY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CANCER IMMUNOTHERAPY COMPANIES

  • 10.1. Cancer Immunotherapy Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF CANCER IMMUNOTHERAPY INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Pfizer Inc
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. AstraZeneca
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Merck & Co. Inc
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. F. Hoffmann-La Roche Ltd
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Bristol-Myers Squibb Company
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Novartis AG
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Lilly
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Johnson & Johnson Services Inc
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Immunocore Ltd
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies